Cyxone Signs a UK Contract Research Organization for Six-month Toxicology Studies With Rabeximod
- Thursday, November 21, 2019, 8:18
- PR Newswire
- Add a comment
STOCKHOLM, Nov. 21, 2019 /PRNewswire/ — Cyxone (publ), a Swedish biotech in autoimmune diseases, announced today that the company has signed an agreement with a UK contract research organization (CRO) to conduct the six-month toxicology studies with Rabeximod as required ahead of the…
About the Author
admin has written 20655 stories on this site.